Pfizer Inc. @pfizer · 28 Aug 2026
As #ESCCongress 2026 returns to Munich, early diagnosis and treatment initiation remain the biggest opportunity to improve outcomes in ATTR-CM, an underdiagnosed cause of heart failure. Explore how the landscape has evolved and what needs to happen next: https://t.co/pzodOzmLkN https://t.co/YkdtiQ3CSb
5 734Views
21Likes
5Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
1.00×vs this author's median5 734 views is typical
46Percentile for this authorof 13 recent posts
0.93×vs 100K–1M median6 139 views is typical
1.22%Reachviews ÷ followers
0.45%Engagement rateof viewers reacted